跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Compound 24
首页
药物
Compound 24
Compound 24
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Anti tumor application of 3-carbonyl-20alpha-hydroxy-24-en-dammarane compound
申请人: UNIV FUJIAN AGRIC & FORESTRY
优先权: 2009
CN
Application of compound DXL-A-24 in preparation of medicine for treating functional abdominal pain syndrome
申请人: SHANGDONG NEW TIME PHARM PROD
优先权: 2020
CN
2-benzo-[3,4-b]quinolino-[b,g]indeno[1,2:3,4]fluoreno-[1,2-d]oxonine-24-flouro-5,11,16,21-tetraone as an antimicrobial compound
申请人: UNIV KING FAISAL
优先权: 2023
US
2-benzo-[3,4-B]quinolino-[b,g]indeno[1′,2′:3,4]fluoreno-[1,2-d]oxonine-24-chloro-5,11,16,21-tetraone as an antimicrobial compound
申请人: UNIV KING FAISAL
优先权: 2023
US
Chinese herbal compound for treating lung cancer
申请人: WANG LEI
优先权: 2015
CN
Method for synthesizing delta 24(28) cholesterol compounds
申请人: THIRD MILTARY MEDICAL UNIVERSI
优先权: 2009
CN
Hypoglycemic agent
申请人: RIKEN JAPAN SCIENCE AND TECHNO
优先权: 2001
US
2 件公开
Application of miR-24 and analogue thereof in prevention and treatment of skin inflammation diseases
申请人: SHANGHAI INST OF NUTRITION AND HEALTH CAS
优先权: 2024
CN
药物
反馈